RxDoctor Payments Data

Amanda Dudley, NP

Family · Indianapolis, INNPI 1023764081

Payments from drug & device makers

$1,122in general payments, 2019–2025

Across 68 payments — averaging $16.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$282
  • Biohaven Pharmaceutical Holding Company Ltd.$74
  • Bayer$73
  • Insulet Corporation$68
  • Novo Nordisk$68
  • Medtronic$58
  • plus $497 from 19 others

What the payments were for

  • Food & beverage$1,122100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,122 in reported general payments places this provider in the 65th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$16,218
Medicare patients
112
Services billed
257

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide34$40,855
EliquisApixaban34$31,836
JardianceEmpagliflozin11$9,786
Albuterol Sulfate HfaAlbuterol Sulfate50$1,785
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,766
Levocetirizine Dihydrochloride30$903
Fluticasone Propionate61$883
Metoprolol Succinate30$816
Losartan Potassium38$720
Pregabalin14$647
Rosuvastatin Calcium36$611
Levothyroxine Sodium42$546
Gabapentin40$494
Bupropion XlBupropion Hcl11$371
Carvedilol21$329

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$43$40,85534 claims
Boehringer IngelheimJardiance$24$9,78611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,392 family providers in Indiana.

Other family in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →